Multiple Myeloma

4 protocols meet the specified criteria
Disease Site: Multiple Myeloma
Protocol No. Title
201400422 A Randomized, Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients up to 65 Years of Age
201500073 iCare for Cancer Patients
201602092 A non-interventional study exploring quality of life in multiple myeloma according to treatment following autologous stem cell transplant
20161600 A Single Arm, Open-Label, Phase 2 Study of Melflufen in Combination with Dexamethasone in Patients with Relapsed Refractory Multiple Myeloma who are Refractory to Pomalidomide and/or Daratumumab